Spots Global Cancer Trial Database for epigenetic
Every month we try and update this database with for epigenetic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors | NCT02414516 | Solid Tumor | OBP-801 | 18 Years - | Oncolys BioPharma Inc | |
| Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS | NCT02204020 | Acute Myeloid L... Myelodysplastic... | 5-azacytidine (... | 18 Years - | University of Pittsburgh | |
| Combining Epigenetic And Immune Therapy to Beat Cancer. | NCT04705818 | Advanced Solid ... Advanced Colore... Advanced Soft-t... Advanced Pancre... Adult Solid Tum... | Durvalumab Tazemetostat | 18 Years - | Institut Bergonié | |
| A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors | NCT02414516 | Solid Tumor | OBP-801 | 18 Years - | Oncolys BioPharma Inc | |
| Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR) | NCT05456074 | Renal Carcinoma | Data collection | - | Institut de cancérologie Strasbourg Europe | |
| Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation | NCT03343834 | Epstein-Barr Vi... Hematologic Dis... Allogeneic Dise... | biological coll... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia | NCT00776503 | Myelodysplastic... | VORINOSTAT | 18 Years - | Groupe Francophone des Myelodysplasies | |
| A Study to Investigate LYL845 in Adults With Solid Tumors | NCT05573035 | Melanoma Non-small Cell ... Colorectal Canc... | LYL845 | 18 Years - 75 Years | Lyell Immunopharma, Inc. | |
| EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors | NCT03481868 | Chronic Myeloid... Chronic Phase | Collection of b... | 18 Years - | University Hospital, Clermont-Ferrand | |
| Genome Sequencing of Human Cancer Tissues | NCT02105545 | Cancer | Cancer Treatmen... | - | New Mexico Cancer Care Alliance | |
| Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia | NCT00776503 | Myelodysplastic... | VORINOSTAT | 18 Years - | Groupe Francophone des Myelodysplasies | |
| A Study to Investigate LYL845 in Adults With Solid Tumors | NCT05573035 | Melanoma Non-small Cell ... Colorectal Canc... | LYL845 | 18 Years - 75 Years | Lyell Immunopharma, Inc. | |
| Essential Hypotension and Allostasis Registry | NCT02018497 | Blood Pressure Depression Panic Attack Fibromyalgia POTS Inappropriate S... Coronary Heart ... Acute Coronary ... Acute Myocardia... Cerebrovascular... Transient Ische... Atrial Fibrilla... Diabetes Mellit... Cancer Systolic Heart ... Diastolic Heart... Chronic Fatigue... Syncope Vasovagal Synco... | - | CES University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
